NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals (NRXP) Financial Statements


NRX Pharmaceuticals Financial Overview

NRX Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.184; its P/E ratio is -0.96; NRX Pharmaceuticals is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.98M$ -4.43M$ -7.38M$ -11.05M$ -9.71M
EBITDA$ -5.98M$ -4.42M$ -7.38M$ -11.05M$ -9.71M
Net Income Common Stockholders$ -6.53M$ -4.33M$ -7.39M$ -11.05M$ -10.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.32M$ 4.59M$ 14.97M$ 16.51M$ 20.05M
Total Assets$ 3.79M$ 7.32M$ 19.81M$ 21.78M$ 25.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.32M$ -4.59M$ -14.97M$ -16.51M$ -20.05M
Total Liabilities$ 18.86M$ 19.05M$ 22.62M$ 22.06M$ 18.41M
Stockholders Equity$ -15.07M$ -11.73M$ -2.81M$ -284.00K$ 7.41M
Cash Flow-
Free Cash Flow$ -3.67M$ -3.19M$ -7.81M$ -6.09M$ -8.32M
Operating Cash Flow$ -3.67M$ -3.19M$ -7.81M$ -6.09M$ -8.32M
Investing Cash Flow-$ 1.00K$ 2.00K$ -4.00K$ 1.00K
Financing Cash Flow$ 395.00K$ -1.12M$ 6.27M$ 2.54M$ 10.12M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

NRX Pharmaceuticals Debt to Assets

NRX Pharmaceuticals Cash Flow

NRX Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis